Cero Therapeutics Holdings, Inc. received a notification from Nasdaq on June 11, 2025, stating that its stock price has been below $1.00 per share for 30 consecutive business days, risking delisting; however, following a reverse stock split on June 13, 2025, the stock traded at $7.31 per share, meeting the minimum requirement.